ID   OUS-11
AC   CVCL_3108
SY   OUS11
DR   BTO; BTO_0003968
DR   BioSample; SAMN03472481
DR   GEO; GSM827565
DR   JCRB; JCRB1034
DR   JCRB; NIHS0313
DR   Wikidata; Q54936819
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Doubling time: ~23 hours (Note=Lot 11102015) (JCRB=JCRB1034).
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from the normal tissue of a lung cancer patient.
CC   Discontinued: JCRB; NIHS0313; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1034
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg, S. Michael
RA   Mohapatra, Gayatry
RA   Rivera, Miguel N.
RA   Winokur, Daniel
RA   Greninger, Patricia
RA   Nitta, Mai
RA   Sadow, Peter M.
RA   Sooriyakumar, Gaya
RA   Brannigan, Brian W.
RA   Ulman, Matthew J.
RA   Perera, Rushika M.
RA   Wang, Rui
RA   Tam, Angela
RA   Ma, Xiao-Jun
RA   Erlander, Mark
RA   Sgroi, Dennis C.
RA   Rocco, James W.
RA   Lingen, Mark W.
RA   Cohen, Ezra E.W.
RA   Louis, David Neil
RA   Settleman, Jeffrey
RA   Haber, Daniel Arie
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//